Sinotherapeutics Inc. (SHA:688247)

China · Delayed Price · Currency is CNY

9.30

+0.14 (1.53%)

At close: Apr 30, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Manufacturing		511.62M	299.87M	247.56M	315.47M	319.16M
Pharmaceutical Manufacturing Growth		70.61%	21.13%	-21.53%	-1.16%	129.84%
Total		511.62M	299.87M	247.56M	315.47M	319.16M
Total Growth		70.61%	21.13%	-21.53%	-1.16%	129.84%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China		303.13M	-	-	-	319.16M
China Growth		-	-	-	-	129.84%
Overseas		207.95M	-	-	-	-
Total		511.08M	-	-	-	319.16M
Total Growth		-	-	-	-	129.84%

Source: S&P Global Market Intelligence.